WebJun 19, 2014 · The paper version of the tool was developed into a mobile application for multiple digital platforms. iscorEB can be used for research purposes or in regular clinical … WebMar 20, 2014 · The final score, Instrument for Scoring Clinical Outcome of Research for Epidermolysis Bullosa (iscorEB), is a combined score that contains clinician items grouped in five domains (skin, mucosa, organ involvement, laboratory abnormalities, and complications and procedures; maximum score 114) and patient-derived items (pain, itch, …
iscorEB APK for Android Download - Apkpure
WebJun 10, 2024 · Changes in iscorEB (instrument for scoring clinical outcomes for research of EB), patient portion score in the intervention versus placebo [24 weeks] iscorEB is a measurement tool for evaluating the disease severity in EB patient. It evaluates the cutaneous, mucosal and other organ impact of EB and includes clinician and patient … WebMay 1, 2024 · SummaryBackground. Epidermolysis bullosa (EB) is a group of rare and currently incurable genetic blistering disorders. As more pathogenic‐driven therapies are b massillon tigers high school
Reliability and validity of the instrument for scoring clinical ...
WebRead reviews, compare customer ratings, see screenshots and learn more about iscorEB. Download iscorEB and enjoy it on your iPhone, iPad and iPod touch. WebDec 5, 2024 · Change in disease severity will be assessed by the instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB). Score will be compared to baseline at several timepoints. Minimum value=0, … WebJan 21, 2024 · The high correlation between the total EBDASI and iscorEB-c scores (Spearman ρ = 0.89 (P <.001)), is a promising result for both scores, as it indicates a good level of agreement on the severity of disease for each patient.22 The correlation was strongest between the iscorEB-c and the EBDASI activity score (Spearman ρ = 0.91 (P … hydro pools cornwall